MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 3.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 366,379 shares of the business services provider's stock after selling 11,380 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.72% of Exponent worth $29,699,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of EXPO. Schonfeld Strategic Advisors LLC acquired a new position in Exponent in the fourth quarter valued at about $232,000. Mercer Global Advisors Inc. ADV raised its stake in Exponent by 35.2% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 2,429 shares of the business services provider's stock worth $216,000 after acquiring an additional 633 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Exponent by 7.3% during the fourth quarter. Ameriprise Financial Inc. now owns 646,026 shares of the business services provider's stock worth $57,561,000 after acquiring an additional 44,002 shares in the last quarter. Algert Global LLC acquired a new position in Exponent during the fourth quarter worth about $1,030,000. Finally, Cetera Investment Advisers raised its stake in Exponent by 3.1% during the fourth quarter. Cetera Investment Advisers now owns 8,903 shares of the business services provider's stock worth $793,000 after acquiring an additional 264 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.
Insider Activity
In related news, CEO Catherine Corrigan sold 4,896 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $71.09, for a total value of $348,056.64. Following the sale, the chief executive officer directly owned 81,342 shares in the company, valued at $5,782,602.78. This represents a 5.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Joseph Sala sold 1,595 shares of the company's stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.
Exponent Trading Down 1.0%
NASDAQ EXPO traded down $0.68 during trading on Friday, hitting $70.27. 65,855 shares of the company's stock were exchanged, compared to its average volume of 330,286. The company has a market cap of $3.55 billion, a PE ratio of 35.16 and a beta of 0.94. Exponent, Inc. has a fifty-two week low of $63.81 and a fifty-two week high of $115.75. The stock's 50 day moving average price is $71.76 and its two-hundred day moving average price is $76.39.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. The firm had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The business's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.57 earnings per share. Analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, September 5th. Exponent's payout ratio is 60.00%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.